Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction

Clinica Chimica Acta

Volumn 310, Issue 2, 2001, Pages 193-197

  Hammerer Lercher, Angelika ^a   Neubauer, Elke ^a   Müller, Silvana ^a   Pachinger, Otmar ^a   Puschendorf, Bernd ^a   Mair, Johannes ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Brain natriuretic peptide; Left ventricular dysfunction; N terminal pro atrial natriuretic peptide; N terminal pro brain natriuretic peptide; Radionuclide ventriculography; Three dimensional echocardiography

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; PRO ATRIAL NATRIURETIC PEPTIDE; PRO BRAIN NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO TERMINAL SEQUENCE; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DISEASE MARKER; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; IMMUNOASSAY; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; HUMANS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0035921136     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00578-2     Document Type: Article

References (22)

1. Natriuretic peptides in assessment of left-ventricular dysfunction
2. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction
3. Consensus recommendations for the management of chronic heart failure
4. Atrial natriuretic peptide elevation in congestive heart failure in human
5. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure
6. Clinical significance of urinary cyclic guanosine monophosphate in diagnosis of heart failure
7. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy
8. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure- Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
9. Natriuretic peptides and cyclic guanosine 3′,5′-monophosphate in asymptomatic and symptomatic left ventricular dysfunction
10. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
11. Biochemical detection of left-ventricular dysfunction
12. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin. New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction
13. Plasma N-Terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population
14. An immunoradiometric assay for brain natriuretic peptide in human plasma
15. Enzyme immunoassays for proBNP fragments (8-29) and (32-57)
16. Enzyme immunoassays for fragments (epitopes) of human proatrial natriuretic peptides
17. Quantitative three-dimensional echocardiography by rapid imaging from multiple transthoracic windows: In vitro validation and initial in vivo studies
18. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction
19. Detection of left ventricular dysfunction after acute myocardial infarction: Comparison of clinical, echocardiographic, and neurohormonal methods
20. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction
21. N-terminal atrial natriuretic peptide and left ventricular geometry and function in a population sample of elderly males
22. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-proBNP): A new marker of cardiac impairment